W H Greene, S C Schimpff, P H Wiernik. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultAge FactorsAgedChildDaunorubicin/therapeutic useFemaleHumansHypersensitivity, Delayed/immunologyImmunity, CellularLeukemia, Monocytic, Acute/drug therapyLeukemia, Monocytic, Acute/immunologyLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/immunologyMaleMercaptopurine/therapeutic useMethotrexate/therapeutic useMiddle AgedNitrobenzenesPrednisone/therapeutic usePrognosisRemission, SpontaneousSex FactorsSkin TestsVincristine/therapeutic use
Substances: See more » NitrobenzenesVincristineMercaptopurinePrednisoneMethotrexateDaunorubicin
Year: 1974 PMID: 4520148
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113